Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Clinical Trial

Published on 09 Mar 2023

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation

in Pharmacology of Infectious Diseases

Amin Rakhshan
Nazanin Farahbakhsh
Ghamartaj Khanbabaee
Seyed Ahmad Tabatabaii
Saeed Sadr
Maryam Hassanzad
Mohammad Sistanizad
Farzaneh Dastan
Mahmoud Hajipour
Amir Reza Bahadori

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130374

6,432 views
4 citations

Review

Published on 08 Mar 2023

Ebanga™: The most recent FDA-approved drug for treating Ebola

in Pharmacology of Infectious Diseases

Elahe Taki
Roya Ghanavati
Tahereh Navidifar
Shirin Dashtbin
Mohsen Heidary
Marjan Moghadamnia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1083429

17,362 views
30 citations

Original Research

Published on 02 Mar 2023

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

in Pharmacology of Infectious Diseases

Sai Shi
Lei Xie
Sen Ma
Binghong Xu
Hailong An
Sheng Ye
Yaxin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118584

3,957 views
5 citations

Review

Published on 02 Mar 2023

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review

in Pharmacology of Infectious Diseases

Jiamin He
Zheng Zhu
Meiyan Sun
Xiaoning Liu
Junwen Yu
Lin Zhang
Hongzhou Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1013688

4,312 views
3 citations

Original Research

Published on 02 Mar 2023

The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study

in Pharmacology of Infectious Diseases

Qian Du
Xin Xi
Jie Dong
Tongyan Zhang
Dongxuan Li
Yuzhu Dong
Wenjun Li
Guili Huang
Jun Zhu
Hailong Ran

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128219

2,307 views
6 citations

Original Research

Published on 01 Mar 2023

Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19

in Pharmacology of Infectious Diseases

Shaibu Oricha Bello
Abdulmajeed Yunusa
Adamu Ahmed Adamu
Mustapha Umar Imam
Muhammad Bashir Bello
Abdulmalik Shuaibu
Ehimario Uche Igumbor
Zaiyad Garba Habib
Mustapha Ayodele Popoola
Chinwe Lucia Ochu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130828

4,233 views
6 citations

Original Research

Published on 24 Feb 2023

Molluskicidal nanoemulsion of Neomitranthes obscura (DC.) N. Silveira for schistosomiasis control

in Pharmacology of Infectious Diseases

Leonardo da Silva Rangel
Francisco Paiva Machado
Raquel Amaral
Ana Cláudia Rodrigues Da Silva
Marcelo Guerra Santos
José Augusto Albuquerque Dos Santos
Natalia Lidmar Von Ranke
Carlos Rangel Rodrigues
Leandro Rocha
Robson Xavier Faria

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1078936

2,501 views

Review

Published on 24 Feb 2023

Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus

in Pharmacology of Infectious Diseases

Xiaoli Li
Yongqing Cai
Qinchuan Xia
Yongqun Liao
Rongxin Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1118793

11,250 views
10 citations

Clinical Trial

Published on 17 Feb 2023

Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial

in Pharmacology of Infectious Diseases

Saghar Barati
Faezeh Feizabadi
Hakimeh Khalaj
Hakimeh Sheikhzadeh
Hamid R. Jamaati
Hirad Farajidavar
Farzaneh Dastan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1102940

5,700 views
4 citations

Data Report

Published on 10 Feb 2023

The challenges of open data for future epidemic preparedness: The experience of the 2022 Ebolavirus outbreak in Uganda

in Pharmacology of Infectious Diseases

Francesco Branda
Ahmed Mahal
Antonello Maruotti
Massimo Pierini
Sandra Mazzoli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101894

5,149 views
18 citations

Original Research

Published on 07 Feb 2023

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development

in Pharmacology of Infectious Diseases

Md. Aminul Islam
Shatila Shahi
Abdullah Al Marzan
Mohammad Ruhul Amin
Mohammad Nayeem Hasan
M. Nazmul Hoque
Ajit Ghosh
Abanti Barua
Abbas Khan
Kuldeep Dhama

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090717

7,454 views
22 citations

Review

Published on 02 Feb 2023

Clofazimine for the treatment of tuberculosis

in Pharmacology of Infectious Diseases

Jacob A. M. Stadler
Gary Maartens
Graeme Meintjes
Sean Wasserman

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1100488

21,704 views
59 citations

Editorial

Published on 01 Feb 2023

Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection

in Pharmacology of Infectious Diseases

Roberta Rizzo
Francesca Caccuri
Giuseppe Valacchi
Giorgio Zauli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1136277

1,495 views
1 citation

Original Research

Published on 01 Feb 2023

Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study

in Pharmacology of Infectious Diseases

Yazed Saleh Alsowaida
Fadi Shehadeh
Markos Kalligeros
Eleftherios Mylonakis

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1106044

3,956 views
16 citations

Editorial

Published on 26 Jan 2023

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II

in Pharmacology of Infectious Diseases

Jaime Ribeiro-Filho
Yanna Carolina Ferreira Teles
John Ogbaji Igoli
Raffaele Capasso

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144074

2,301 views
1 citation

Mini Review

Published on 24 Jan 2023

Phages against killer superbugs: An enticing strategy against antibiotics-resistant pathogens

in Pharmacology of Infectious Diseases

Bikash Baral

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1036051

9,333 views
15 citations

Original Research

Published on 17 Jan 2023

Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study

in Pharmacology of Infectious Diseases

Maryam Hajimoradi
Babak Sharif Kashani
Farzaneh Dastan
Sina Aghdasi
Atefeh Abedini
Farah Naghashzadeh
Arezoo Mohamadifar
Mohammad Sadegh Keshmiri
Sima Noorali
Somayeh Lookzadeh

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1107198

5,025 views
9 citations

Original Research

Published on 13 Jan 2023

Development and validation of two bioanalysis methods for the determination of etimicin in human serum and urine by liquid chromatography-tandem mass spectrometry: Applications to a human pharmacokinetic and breakpoint study

in Pharmacology of Infectious Diseases

Xinge Cui
Xin Zheng
Jianwei Ren
Hongzhong Liu
Yuan Jia
Aiguo Wu
Xiaohong Han

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1076046

3,272 views
4 citations

Systematic Review

Published on 09 Jan 2023

Activity of the genus Zanthoxylum against diseases caused by protozoa: A systematic review

in Pharmacology of Infectious Diseases

Juliana Correa-Barbosa
Daniele Ferreira Sodré
Pedro Henrique Costa Nascimento
Maria Fâni Dolabela

Frontiers in Pharmacology

doi 10.3389/fphar.2022.873208

4,009 views
6 citations

Original Research

Published on 09 Jan 2023

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis

in Pharmacology of Infectious Diseases

Haoyue Zhang
Yuying He
Lina Davies Forsman
Jakob Paues
Jim Werngren
Katarina Niward
Thomas Schön
Judith Bruchfeld
Jan-Willem Alffenaar
Yi Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1032674

5,452 views
11 citations

Opinion

Published on 05 Jan 2023

How and when does monkeypox (mpox) transmit: Implications for prevention and treatments

in Pharmacology of Infectious Diseases

Shu Yuan
Si-Cong Jiang
Zhong-Wei Zhang
Yu-Fan Fu
Xin-Yue Yang
Zi-Lin Li
Jing Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1109928

4,312 views
6 citations

Original Research

Published on 04 Jan 2023

Successful establishment and five-year sustainability of a neonatal-specific antimicrobial stewardship program in a low middle-income country

in Pharmacology of Infectious Diseases

Faouzi I. Maalouf
Therese Saad
Ramia Zakhour
Khalid Yunis

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1076392

3,089 views
10 citations

Original Research

Published on 04 Jan 2023

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India

in Pharmacology of Infectious Diseases

Juan Eduardo Resendiz-Galvan
Prerna R. Arora
Mahmoud Tareq Abdelwahab
Zarir F. Udwadia
Camilla Rodrigues
Amita Gupta
Paolo Denti
Tester F. Ashavaid
Jeffrey A. Tornheim

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081123

5,422 views
6 citations

Original Research

Published on 20 Dec 2022

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters

in Pharmacology of Infectious Diseases

Rana Abdelnabi
Piet Maes
Steven de Jonghe
Birgit Weynand
Johan Neyts

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1072202

6,025 views
22 citations

439 articles

articles

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation

Ebanga™: The most recent FDA-approved drug for treating Ebola

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review

The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes: A prospective historically controlled study

Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19

Molluskicidal nanoemulsion of Neomitranthes obscura (DC.) N. Silveira for schistosomiasis control

Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus

Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial

The challenges of open data for future epidemic preparedness: The experience of the 2022 Ebolavirus outbreak in Uganda

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development

Clofazimine for the treatment of tuberculosis

Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection

Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II

Phages against killer superbugs: An enticing strategy against antibiotics-resistant pathogens

Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study

Development and validation of two bioanalysis methods for the determination of etimicin in human serum and urine by liquid chromatography-tandem mass spectrometry: Applications to a human pharmacokinetic and breakpoint study

Activity of the genus Zanthoxylum against diseases caused by protozoa: A systematic review

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis

How and when does monkeypox (mpox) transmit: Implications for prevention and treatments

Successful establishment and five-year sustainability of a neonatal-specific antimicrobial stewardship program in a low middle-income country

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters